Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2/3 × Depression × Oxygen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Conditions

Paresthesia 2 Hypesthesia 2 Depression 2 Anxiety Disorders 2

Interventions

Oxygen 2 Melatonin 2 Ultraviolet Therapy 1 Surveys and Questionnaires 1 Saline Solution 1 Referral and Consultation 1 Mindfulness-Based Stress Reduction 1 Methylphenidate 1 Ketamine 1 Fatty Acids, Omega-3 1 Desvenlafaxine Succinate 1 Cognitive Behavioral Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06799351 2025-02-12

OzoParQTmicrob

Dr. Negrin University Hospital

Phase 2/3 Recruiting

Anxiety Disorders, Depression, Hypesthesia, Paresthesia

NCT06706544 2025-02-11

OzoParQT

Dr. Negrin University Hospital

Phase 2/3 Recruiting

Anxiety Disorders, Depression, Hypesthesia, Paresthesia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡